Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Danaflex-Lab ApS
APS
Active
Advertising protection
CVR 43725157
Gefionsvej 20, 3400
Hillerød
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2022 · 3 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Danaflex-Lab ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2023
2024
2025
Gross profit
-103
323
493
Staff expenses
-0
-0
-328
EBITDA
-103
323
165
Depreciation & amort.
-0
-0
-0
EBIT
-103
323
165
Net financials
-8
-5
69
Profit before tax
-112
317
234
Tax
-25
70
27
Net profit
-87
247
206
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
731
978
760
Equity
-47
200
406
Long-term debt
0
0
0
Short-term debt
778
778
353
Total debt
778
778
353
Financial ratios
5-year trend
EBITDA margin (of gross profit)
33.4%
This company
2023
2025
Equity ratio
53.5%
This company
38.2%
Market median
+40% vs market
2023
2025
Return on equity
50.8%
This company
18.4%
Market median
+176% vs market
2023
2025
Net profit margin (of gross profit)
41.9%
This company
2023
2025
Asset turnover (of gross profit)
0.65×
This company
2023
2025
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-12-20 – 2023-12-31
View
PDF
More on Danaflex-Lab ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
